A poster from a different board asked a series of questions to IR (Dominique) and here is his response. Take it for what it's worth, but IMO info to digest whatever your position/outlook. With regard to your questions, I’m actively working with the team on a corporate update that will encompass context for 2023 as you suggest, recent events (SHOT show, etc.) outstanding bids, Blueforce, FMS, and more. With regard to POs, I don’t have much of an update to provide at the moment. We continue our regular flow of sales through our MAS. With the new year also comes new pricing and the possibility for economic adjustments so we’ve been actively updating the MAS accordingly while also adding other products. As you suggest, a lot of the focus has been on revenue generation, specifically recurring revenues. We have several partnerships with vendors that would allow us to meet our objectives, and Blueforce aligns with that goal. We’ve also been working with other groups on FMS for sustained orders of healthcare supplies and other needs including CBRNE. As I’ve alluded to in conversations with shareholders, we have actively dived into the Canadian market for opportunities that will allow the company to create recurring revenues by making its offering available to the Canadian government and the retail market. Finally, from the contracting standpoint, as shareholders continue to witness, there hasn’t been much movement from the US government. Gowns, as a key example, remain outstanding.